156 related articles for article (PubMed ID: 8254296)
1. The effect of acute pharmacological manipulation of central serotonin neurotransmission on osmoregulated secretion of arginine vasopressin in the rat.
Faull CM; Charlton JA; Butler TJ; Baylis PH
J Endocrinol; 1993 Oct; 139(1):77-87. PubMed ID: 8254296
[TBL] [Abstract][Full Text] [Related]
2. The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man.
Faull CM; Rooke P; Baylis PH
Clin Endocrinol (Oxf); 1991 Nov; 35(5):423-30. PubMed ID: 1814657
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
4. Disturbance of osmoregulated thirst and vasopressin secretion in thyrotoxicosis.
Harvey JN; Nagi DK; Baylis PH; Wilkinson R; Belchetz PE
Clin Endocrinol (Oxf); 1991 Jul; 35(1):29-33. PubMed ID: 1889137
[TBL] [Abstract][Full Text] [Related]
5. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells.
Calogero AE; Bagdy G; Moncada ML; D'Agata R
J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213
[TBL] [Abstract][Full Text] [Related]
6. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
8. Effect of an increase in brain serotonin on the osmoregulatory response to a hypo- or hyperosmotic load in Wistar and vasopressin-deficient Brattleboro rats.
Ivanova L; Kochkaeva L; Melidi N
Neuroendocrinology; 2007; 85(4):242-8. PubMed ID: 17541259
[TBL] [Abstract][Full Text] [Related]
9. The effect of modulation of central serotonin neurotransmission on osmoregulated vasopressin release in rats.
Faull CM; Charlton JA; Phillips E; Thornton S; Butler T; Baylis PH
Ann N Y Acad Sci; 1993 Jul; 689():484-8. PubMed ID: 8396874
[No Abstract] [Full Text] [Related]
10. Involvement of anteroventral third ventricular AMPA/kainate receptors in both hyperosmotic and hypovolemic AVP secretion in conscious rats.
Yamaguchi K; Yamada T
Brain Res Bull; 2006 Dec; 71(1-3):183-92. PubMed ID: 17113945
[TBL] [Abstract][Full Text] [Related]
11. Osmoregulation of vasopressin secretion in the insulin-withdrawn streptozotocin-treated diabetic rat.
Charlton JA; Thompson CJ; Palmer JM; Thornton S; Baylis PH
J Endocrinol; 1989 Dec; 123(3):413-9. PubMed ID: 2607251
[TBL] [Abstract][Full Text] [Related]
12. Osmotic threshold and sensitivity for vasopressin release and fos expression by hypertonic NaCl in ovine fetus.
Xu Z; Glenda C; Day L; Yao J; Ross MG
Am J Physiol Endocrinol Metab; 2000 Dec; 279(6):E1207-15. PubMed ID: 11093906
[TBL] [Abstract][Full Text] [Related]
13. Arginine vasopressin, fluid balance and exercise: is exercise-associated hyponatraemia a disorder of arginine vasopressin secretion?
Hew-Butler T
Sports Med; 2010 Jun; 40(6):459-79. PubMed ID: 20524712
[TBL] [Abstract][Full Text] [Related]
14. Effects of changes in plasma hepatic-portal and systemic osmolality on plasma concentrations of arginine vasopressin in conscious newborn calves.
Kati-Coulibaly S; Giry J; Barlet JP
J Dev Physiol; 1989 Oct; 12(4):183-7. PubMed ID: 2634058
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
16. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms.
Dedeoğlu A; Fisher LA
J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059
[TBL] [Abstract][Full Text] [Related]
17. Effects of antihypertensive treatment on vasopressin secretion and on its osmoregulation in moderate hypertension.
Del Bo A; Suraci S; Giuditta M; Mistò M; Zanchetti A
J Hypertens; 1997 Nov; 15(11):1277-83. PubMed ID: 9383177
[TBL] [Abstract][Full Text] [Related]
18. An inhibitor of leukotriene synthesis affects vasopressin secretion following osmotic stimulus in rats.
dos Santos JF; de Oliveira-Pelegrin GR; Athayde LA; da Rocha MJ
Regul Pept; 2012 Nov; 179(1-3):6-9. PubMed ID: 22960410
[TBL] [Abstract][Full Text] [Related]
19. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women.
Stachenfeld NS; DiPietro L; Palter SF; Nadel ER
Am J Physiol; 1998 Jan; 274(1):R187-95. PubMed ID: 9458917
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
